Back to Trades
Kewalramani Reshma
CEO & PresidentDirectorCIK 0001735944
Profile
- Filings
- 6
- Buy transactions
- 2
- Sell transactions
- 0
- Companies
- 1
- Active
- 2025–2026
Kewalramani Reshma, CEO & President, Director, has filed 6 reports across 1 company, totaling $19.7M in disclosed volume. The predominance of buying ($3.9M in purchases vs. $0 in sales) may reflect confidence in the underlying companies. All data sourced from SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
6 loaded
| Feb 26 | VRTX VERTEX PHARMACEUTICALS INC / MA | Kewalramani Reshma | CEO & President, Director | Other | $0 |
| Feb 19 | VRTX VERTEX PHARMACEUTICALS INC / MA | Kewalramani Reshma | CEO & President, Director | Grant | $0 |
| Feb 18 | VRTX VERTEX PHARMACEUTICALS INC / MA | Kewalramani Reshma | CEO & President, Director | Other | $0 |
| Feb 12 | VRTX VERTEX PHARMACEUTICALS INC / MA | Kewalramani Reshma | CEO & President, Director | Other | $0 |
| Jan 26 | VRTX VERTEX PHARMACEUTICALS INC / MA | Kewalramani Reshma | CEO & President, Director | Grant | $0 |
| Aug 7 | VRTX VERTEX PHARMACEUTICALS INC / MA | Kewalramani Reshma | CEO & President, Director | Buy | $3.9M |
6 filings